๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mutation in blood coagulation factor V associated with resistance to activated protein C

โœ Scribed by van der Velden, Pieter A.; Reitsma, Pieter H.; Bertina, Rogier M.; Koeleman, Bobby P. C.; Koster, Ted; Rosendaal, Frits R.; Dirven, Richard J.; de Ronde, Hans

Book ID
109788474
Publisher
Nature Publishing Group
Year
1994
Tongue
English
Weight
513 KB
Volume
369
Category
Article
ISSN
0028-0836

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Activated protein C resistance and the f
Activated protein C resistance and the factor V Leiden mutation in children with thrombosis
โœ Sifontes, Maria T.; Nuss, Rachelle; Hunger, Stephen P.; Waters, Jill; Jacobson, ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 22 KB ๐Ÿ‘ 2 views

To determine the prevalence of activated protein C resistance and the factor V Leiden mutation (position 1691, arginine 506 to glutamine substitution) in children with thrombosis, plasma samples from children with thrombosis were tested for activated protein C resistance. DNA was analyzed for the fa

Resistance to activated protein C due to
Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers
โœ Y. Gaber; H-J. Siemens; W. Schmeller ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 201 KB

## Background: Activated protein c (apc) resistance is the most frequently diagnosed heritable thrombophilic defect predisposing to thrombosis. ## Objectives: To determine the prevalence of apc resistance due to factor v leiden mutation in patients with leg ulcers. ## Methods: Within a 2-year-p

Evidence against heterozygous coagulatio
Evidence against heterozygous coagulation factor V 1691 Gโ†’A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction
โœ W. Prohaska; H. Mannebach; M. Schmidt; U. Gleichmann; K. Kleesiek ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 327 KB

The aim of our study was to determine the prevalence of the factor V mutation (position 1691 G->A) in patients with angiographically diagnosed coronary artery disease and myocardial infarction and, as a control, in blood donors. This mutation has already been proved to be the main genetic risk facto